Skip to content
10-Q

Quarterly Report

CONTEXT THERAPEUTICS INC. CNTX

0001628280-26-031267

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 4, 2026 91.88M sh
Shares Diluted Q1 2026 · Mar 31, 2026 95.18M sh
Shares Diluted Q1 2026 · Mar 31, 2025 95.19M sh
Capex Q1 2026 · Mar 31, 2026 $37.26K
Capex Q1 2026 · Mar 31, 2025 $33.95K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$11.43M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$5.03M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $54.53M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $66M
Stockholders Equity Q1 2026 · Mar 31, 2026 $52.2M
Stockholders Equity Q1 2026 · Dec 31, 2025 $60.47M
Stockholders Equity Q1 2026 · Mar 31, 2025 $90.98M
Stockholders Equity Q1 2026 · Dec 31, 2024 $95.27M
Current Liabilities Q1 2026 · Mar 31, 2026 $6.53M
Current Liabilities Q1 2026 · Dec 31, 2025 $8.02M
Total Liabilities Q1 2026 · Mar 31, 2026 $6.66M
Total Liabilities Q1 2026 · Dec 31, 2025 $8.02M
Current Assets Q1 2026 · Mar 31, 2026 $58.52M
Current Assets Q1 2026 · Dec 31, 2025 $68.35M
Total Assets Q1 2026 · Mar 31, 2026 $58.86M
Total Assets Q1 2026 · Dec 31, 2025 $68.49M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.09
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.05
Eps Basic Q1 2026 · Mar 31, 2026 −$0.09
Eps Basic Q1 2026 · Mar 31, 2025 −$0.05
Sga Expense Q1 2026 · Mar 31, 2026 $2.33M
Sga Expense Q1 2026 · Mar 31, 2025 $2.07M
Net Income Q1 2026 · Mar 31, 2026 −$8.68M
Net Income Q1 2026 · Mar 31, 2025 −$4.58M
Operating Income Q1 2026 · Mar 31, 2026 −$9.34M
Operating Income Q1 2026 · Mar 31, 2025 −$5.53M